MAZE Maze Therapeutics, Inc. - Common Stock
$25,36
Kurs · Mai 20, 2026
Fundamentaldaten per Mai 12, 2026
52W-Spanne
$9–$54
36% of range
Analystenbewertung
BUY
12 analysts
Kursziel
$63
+148% upside
P/E (TTM)
-13.6
ROE
-598.9%
Nettogewinnmarge
—
MAZE Aktien-Snapshot Kurs, Marktkapitalisierung, P/E, EPS, ROE, Schulden/Eigenkapital, 52-Wochen-Spanne
Kurs
$25.36
Marktkapitalisierung
$2.04B
P/E (TTM)
-13.6
EPS (TTM)
$-3.05
Umsatz (TTM)
$168M
Dividendenrendite
—
ROE
-598.9%
Verschuldungsgrad
—
52W-Spanne
$9 – $54
MAZE Aktienkurs-Chart Täglich OHLCV mit technischen Indikatoren — Schwenken, Zoom und Ansicht anpassen
Configure
10-Jahres-Performance Umsatz-, Nettoergebnis-, Margen- und EPS-Trends
Umsatz & Nettoergebnis
$168M
2024-12-31
→
2024-12-31
EPS
$-3.05
2024-12-31
→
2025-12-31
Freier Cashflow
$-113M
2025-12-31
→
2025-12-31
Margen
—
Bewertung P/E-, P/S-, P/B-, EV/EBITDA-Verhältnisse — ist die Aktie teuer oder günstig?
Kennzahl
5-Jahres-Trend
MAZE
Peer-Median
P/E (TTM)
-13.6
22.4
P/B (K/B)
5.8
4.6
Price / FCF (Kurs / FCF)
-18.1
—
Rentabilität Brutto-, Betriebs- und Nettomargen; ROE, ROA, ROIC
Kennzahl
5-Jahres-Trend
MAZE
Peer-Median
ROA
-41.1%
-7.1%
ROE
-598.9%
-18.6%
ROIC
-40.3%
—
Finanzielle Gesundheit Verschuldung, Liquidität, Solvenz — Bilanzstärke
Kennzahl
5-Jahres-Trend
MAZE
Peer-Median
Current Ratio (Liquiditätsgrad)
15.5
3.9
Quick Ratio
15.2
—
Wachstum Umsatz-, EPS- und Nettoergebniswachstum: YoY, 3-Jahres-CAGR, 5-Jahres-CAGR
Kennzahl
5-Jahres-Trend
MAZE
Peer-Median
Kapitaleffizienz Umsatz pro Vermögenswert, Lagerumschlag, Forderungsumschlag
Kennzahl
5-Jahres-Trend
MAZE
Peer-Median
MAZE Analysten-Konsens Bullische und bärische Analystenmeinungen, 12-Monats-Kursziel, Aufwärtspotenzial
KAUF
12 Analysten
- Starker Kauf 5 41,7%
- Kauf 6 50,0%
- Halten 1 8,3%
- Verkauf 0 0,0%
- Starker Verkauf 0 0,0%
12-Monats-Kursziel
11 Analysten · 2026-05-16
Median
$56.00
Mittelwert
$63.00
← Unter allen Zielen
$25.36
Tief
$46.00
Hoch
$110.00
Median-Ziel
$56.00
+120,8%
Mittelwert-Ziel
$63.00
+148,4%
Ergebnisverlauf EPS Ist vs. Schätzung, Überraschung %, Beat-Rate, nächstes Ergebnisdatum
Durchschn. Überraschung
-3.1%
| Zeitraum | EPS Actual | EPS est. | Überraschung |
|---|---|---|---|
| 31. März 2026 | $-0.45 | $-0.56 | 0.11% |
| 31. Dezember 2025 | $-0.65 | $-0.73 | 0.08% |
| 30. September 2025 | $-0.66 | $-0.72 | 0.06% |
| 30. Juni 2025 | $-0.77 | $-0.87 | 0.10% |
| 31. März 2025 | $-1.15 | $-0.77 | -0.38% |
| 31. Dezember 2024 | $-18.32 | $0.46 | -18.8% |
Vergleich mit Konkurrenten Wichtige Kennzahlen im Vergleich zu Branchenkollegen
| Ticker | Marktkapitalisierung | P/E | Umsatz Vj. | Nettomarge | ROE | Bruttogewinnmarge |
|---|---|---|---|---|---|---|
| MAZE | $2.04B | -13.6 | — | — | -598.9% | — |
| INVA | — | 6.1 | 14.7% | — | — | — |
| NUVB | $3.03B | -14.9 | 699.0% | -325.3% | -60.3% | — |
| ATAI | $223M | -1.4 | -1.9% | -48464.0% | -83.1% | — |
| MBX | $1.42B | -13.3 | — | — | -29.6% | — |
| AMLX | $1.33B | -7.9 | -77.1% | — | -61.2% | — |
| PAHC | — | 21.5 | 27.4% | 3.7% | 17.8% | 30.9% |
| SEPN | $1.25B | -25.3 | 4174.5% | -106.4% | -12.9% | — |
| HROW | $1.82B | -350.0 | 36.4% | -1.9% | -8.4% | 75.0% |
| COLL | $1.47B | 26.8 | 23.6% | 8.1% | 23.5% | 59.4% |
Vollständige Fundamentaldaten Alle Kennzahlen nach Jahr — Gewinn- und Verlustrechnung, Bilanz, Cashflow
Gewinn- und Verlustrechnung 13
| Kennzahl | Trend | 2025 | 2024 |
|---|---|---|---|
| Revenue | · | $168M | |
| R&D Expense | $108M | $83M | |
| SG&A Expense | $34M | $26M | |
| Operating Expenses | $143M | $110M | |
| Operating Income | $-143M | $58M | |
| Pretax Income | $-131M | $53M | |
| Income Tax | $0 | $1M | |
| Net Income | $-131M | $52M | |
| EPS (Basic) | $-3.05 | $1.42 | |
| EPS (Diluted) | $-3.05 | $1.25 | |
| Shares (Basic) | 42,976,024 | 2,396,094 | |
| Shares (Diluted) | 42,976,024 | 2,730,299 | |
| EBITDA | $-143M | · |
Bilanz 20
| Kennzahl | Trend | 2025 | 2024 |
|---|---|---|---|
| Cash & Equivalents | $189M | $197M | |
| Short-term Investments | $153M | · | |
| Prepaid Expense | $8M | $5M | |
| Current Assets | $350M | $202M | |
| PP&E (Net) | $5M | $7M | |
| PP&E (Gross) | $24M | $24M | |
| Accum. Depreciation | $19M | $17M | |
| Other Non-current Assets | $3M | $8M | |
| Total Assets | $397M | $241M | |
| Accounts Payable | $2M | $2M | |
| Current Liabilities | $23M | $21M | |
| Capital Leases | $19M | $22M | |
| Other Non-current Liabilities | $1M | $969.0K | |
| Total Liabilities | $42M | $44M | |
| Common Stock | $49.0K | $2.0K | |
| Paid-in Capital | $844M | $47M | |
| Retained Earnings | $-490M | $-358M | |
| Stockholders' Equity | $355M | $-311M | |
| Liabilities + Equity | $397M | $241M | |
| Shares Outstanding | 49,335,551 | 2,446,864 |
Cashflow 7
| Kennzahl | Trend | 2025 | 2024 |
|---|---|---|---|
| Stock-based Comp | $16M | $10M | |
| Operating Cash Flow | $-112M | $76M | |
| CapEx | $794.0K | $1M | |
| Investing Cash Flow | $-171M | $-1M | |
| Financing Cash Flow | $275M | $93M | |
| Taxes Paid | · | $1M | |
| Free Cash Flow | $-113M | · |
Rentabilität 3
| Kennzahl | Trend | 2025 | 2024 |
|---|---|---|---|
| ROA | -41.1% | · | |
| ROE | -598.9% | · | |
| ROIC | -40.3% | · |
Liquidität & Solvenz 2
| Kennzahl | Trend | 2025 | 2024 |
|---|---|---|---|
| Current Ratio | 15.5 | · | |
| Quick Ratio | 15.2 | · |
Bewertung (TTM) 9
| Kennzahl | Trend | 2025 | 2024 |
|---|---|---|---|
| Revenue TTM | · | $168M | |
| Net Income TTM | $-131M | $52M | |
| Market Cap | $2.04B | · | |
| P/E | -13.6 | · | |
| P/B | 5.8 | · | |
| P / Tangible Book | 5.8 | · | |
| P / Cash Flow | -18.3 | · | |
| P / FCF | -18.1 | · | |
| Earnings Yield | -7.4% | · |
Gewinn- und Verlustrechnung 14
| Kennzahl | Trend | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q2 2024 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $20M | · | · | $0 | · | $0 | $165M | |
| R&D Expense | $34M | $28M | $25M | $28M | $28M | $22M | $20M | |
| SG&A Expense | $12M | $10M | $8M | $8M | $8M | $8M | $6M | |
| Operating Expenses | $47M | $38M | $33M | $36M | $35M | $30M | $25M | |
| Operating Income | $-27M | $-38M | $-33M | $-36M | $-35M | $-30M | $140M | |
| Other Non-op | $2M | · | · | · | $3M | · | · | |
| Pretax Income | · | $-35M | $-30M | $-34M | $-33M | $-30M | $141M | |
| Income Tax | · | $0 | $0 | $0 | · | $-275.0K | $2M | |
| Net Income | $-24M | $-35M | $-30M | $-34M | $-33M | $-30M | $139M | |
| EPS (Basic) | $-0.45 | $-0.47 | $-0.66 | $-0.77 | $-1.15 | $19.66 | $5.92 | |
| EPS (Diluted) | $-0.45 | $-0.47 | $-0.66 | $-0.77 | $-1.15 | $22.19 | $3.22 | |
| Shares (Basic) | 53,897,216 | -75,229,404 | 45,779,577 | 43,797,421 | 28,628,430 | -4,745,535 | 2,389,119 | |
| Shares (Diluted) | 53,897,216 | -75,229,404 | 45,779,577 | 43,797,421 | 28,628,430 | -6,336,570 | 4,314,359 | |
| EBITDA | $-27M | · | $-33M | $-36M | $-35M | · | · |
Bilanz 23
| Kennzahl | Trend | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q2 2024 |
|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $199M | $189M | $317M | $265M | $294M | $197M | · | |
| Short-term Investments | $154M | $153M | $67M | · | · | · | · | |
| Receivables | $20M | · | · | · | · | · | · | |
| Prepaid Expense | $7M | $8M | $7M | $7M | $5M | $5M | · | |
| Current Assets | $380M | $350M | $391M | $271M | $300M | $202M | · | |
| PP&E (Net) | $5M | $5M | $6M | $6M | $6M | $7M | · | |
| PP&E (Gross) | · | $24M | · | · | · | $24M | · | |
| Accum. Depreciation | · | $19M | · | · | · | $17M | · | |
| Other Non-current Assets | $4M | $3M | $3M | $4M | $3M | $8M | · | |
| Total Assets | $420M | $397M | $422M | $304M | $333M | $241M | · | |
| Accounts Payable | $4M | $2M | $3M | $4M | $2M | $2M | · | |
| Current Liabilities | $21M | $23M | $22M | $20M | $19M | $21M | · | |
| Capital Leases | $18M | $19M | $19M | $20M | $21M | $22M | · | |
| Other Non-current Liabilities | $388.0K | $1M | $1M | $1M | $1M | $969.0K | · | |
| Total Liabilities | $78M | $42M | $43M | $41M | $41M | $44M | · | |
| Long-term Debt | $39M | · | · | · | · | · | · | |
| Total Debt | $39M | · | · | · | · | · | · | |
| Common Stock | $50.0K | $49.0K | $48.0K | $44.0K | $44.0K | $2.0K | · | |
| Paid-in Capital | $856M | $844M | $834M | $687M | $683M | $47M | · | |
| Retained Earnings | $-514M | $-490M | $-455M | $-425M | $-391M | $-358M | · | |
| Stockholders' Equity | $342M | $355M | $379M | $262M | $292M | $-311M | · | |
| Liabilities + Equity | $420M | $397M | $422M | $304M | $333M | $241M | · | |
| Shares Outstanding | 49,737,619 | 49,335,551 | 48,076,885 | 43,850,884 | 43,797,166 | 2,446,864 | · |
Cashflow 7
| Kennzahl | Trend | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q2 2024 |
|---|---|---|---|---|---|---|---|---|
| Stock-based Comp | $7M | $6M | $4M | $3M | $3M | $3M | $2M | |
| Operating Cash Flow | $-39M | $-28M | $-25M | $-30M | $-30M | $-22M | $145M | |
| CapEx | $93.0K | $34.0K | $68.0K | $393.0K | $299.0K | $605.0K | $160.0K | |
| Investing Cash Flow | $6M | $-103M | $-67M | $-393.0K | $-299.0K | $-605.0K | $-160.0K | |
| Financing Cash Flow | $42M | $4M | $144M | $612.0K | $127M | $70M | $154.0K | |
| Taxes Paid | · | · | · | · | · | $0 | · | |
| Free Cash Flow | $-39M | · | · | · | $-30M | · | · |
Rentabilität 6
| Kennzahl | Trend | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q2 2024 |
|---|---|---|---|---|---|---|---|---|
| Operating Margin | -132.8% | · | · | · | · | · | · | |
| Net Margin | -121.0% | · | · | · | · | · | · | |
| EBITDA Margin | -132.8% | · | · | · | · | · | · | |
| ROA | -6.4% | · | -14.3% | -22.2% | -19.7% | · | · | |
| ROE | -7.6% | · | -15.9% | -25.7% | -22.4% | · | · | |
| ROIC | · | · | -8.7% | -13.9% | · | · | · |
Liquidität & Solvenz 4
| Kennzahl | Trend | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q2 2024 |
|---|---|---|---|---|---|---|---|---|
| Current Ratio | 17.9 | · | 17.7 | 13.6 | 16.1 | · | · | |
| Quick Ratio | 17.5 | · | 17.4 | 13.3 | 15.8 | · | · | |
| Debt / Equity | 0.1 | · | · | · | · | · | · | |
| LT Debt / Equity | 0.1 | · | · | · | · | · | · |
Effizienz 2
| Kennzahl | Trend | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q2 2024 |
|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.1 | · | · | 0.0 | · | · | · | |
| Receivables Turnover | 2.0 | · | · | · | · | · | · |
Bewertung (TTM) 11
| Kennzahl | Trend | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q2 2024 |
|---|---|---|---|---|---|---|---|---|
| Net Income TTM | $-121M | · | $-121M | $48M | $49M | · | · | |
| Market Cap | $1.48B | · | $1.25B | $538M | $482M | · | · | |
| Enterprise Value | $1.17B | · | · | · | · | · | · | |
| P/E | -9.9 | · | -2.0 | -1.4 | -0.5 | · | · | |
| P/B | 4.3 | · | 3.3 | 2.1 | 1.7 | · | · | |
| P / Tangible Book | 4.3 | · | 3.3 | 2.1 | 1.7 | · | · | |
| P / Cash Flow | -38.0 | · | · | · | -16.3 | · | · | |
| P / FCF | -37.9 | · | · | · | -16.2 | · | · | |
| EV / EBITDA | -44.1 | · | · | · | · | · | · | |
| EV / FCF | -29.9 | · | · | · | · | · | · | |
| Earnings Yield | -10.2% | · | -49.5% | -72.9% | -200.6% | · | · |
Finanzberichte Gewinn- und Verlustrechnung, Bilanz, Cashflow — jährlich, letzte 5 Jahre
Gewinn- und Verlustrechnung
| 2025-12-31 | 2024-12-31 | |
|---|---|---|
| Umsatz | — | $168M |
| Nettoergebnis | $-131M | $52M |
| Verwässerte EPS | $-3.05 | $1.25 |
Bilanz
| 2025-12-31 | 2024-12-31 | |
|---|---|---|
| Liquiditätsgrad | 15.5 | — |
| Quick Ratio | 15.2 | — |
Cashflow
| 2025-12-31 | 2024-12-31 | |
|---|---|---|
| Freier Cashflow | $-113M | — |
Neueste Nachrichten Aktuelle Schlagzeilen über dieses Unternehmen
Meine Kennzahlen Ihre persönliche Watchlist — ausgewählte Zeilen aus den vollständigen Fundamentaldaten
📊
Wählen Sie die Kennzahlen, die für Sie wichtig sind — klicken Sie auf das ➕ neben jeder Zeile in den vollständigen Fundamentaldaten oben.
Ihre Auswahl wird gespeichert und begleitet Sie über alle Ticker hinweg.